Cargando…

Frequency Evaluation of the Interleukin-6 −174G>C Polymorphism and Homeostatic Iron Regulator (HFE) Mutations as Disease Modifiers in Patients Affected by Systemic Lupus Erythematosus and Rheumatoid Arthritis

Autoimmune diseases are generally characterized by a multifactorial etiology and are often associated with a genetic predisposition. Both iron metabolism and the inflammatory cytokine system have been shown to play a pivotal role in the dysregulation of the immune response in many different autoimmu...

Descripción completa

Detalles Bibliográficos
Autores principales: Carini, Mattia, Fredi, Micaela, Cavazzana, Ilaria, Bresciani, Roberto, Ferrari, Fabiana, Monti, Eugenio, Franceschini, Franco, Biasiotto, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671518/
https://www.ncbi.nlm.nih.gov/pubmed/38003490
http://dx.doi.org/10.3390/ijms242216300
_version_ 1785149426180816896
author Carini, Mattia
Fredi, Micaela
Cavazzana, Ilaria
Bresciani, Roberto
Ferrari, Fabiana
Monti, Eugenio
Franceschini, Franco
Biasiotto, Giorgio
author_facet Carini, Mattia
Fredi, Micaela
Cavazzana, Ilaria
Bresciani, Roberto
Ferrari, Fabiana
Monti, Eugenio
Franceschini, Franco
Biasiotto, Giorgio
author_sort Carini, Mattia
collection PubMed
description Autoimmune diseases are generally characterized by a multifactorial etiology and are often associated with a genetic predisposition. Both iron metabolism and the inflammatory cytokine system have been shown to play a pivotal role in the dysregulation of the immune response in many different autoimmune conditions, rheumatologic diseases included. The purpose of this work was to analyze the frequency of mutations altering the expression of IL-6 or influencing iron metabolism in patients affected by autoimmune diseases such as Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE). In this study, 144 patients were enrolled: 77 and 67 patients were affected by RA and SLE, respectively. In these cohorts, the frequency of the IL-6 polymorphism −174G>C located in the IL-6 gene promoter was tested. Moreover, the frequencies of the three HFE gene variations associated with iron overload were analyzed: p.His63Asp, p.Ser65Cys and p.Cys282Tyr. The two mutations p.His63Asp and p.Ser65Cys in the HFE gene did not reach statistical significance in any of the comparisons, regardless of the statistical model, cohorts of patients and control populations analyzed. The frequencies of the p.Cys282Tyr mutation and the IL-6 polymorphism −174G>C were found to be overall significantly decreased in RA and SLE patients when the Dominant model and Allele contrast were adopted with both the Odds Ratio and Chi-square. Although further investigation is needed, the examination of the frequencies of the −174G>C IL-6 promoter polymorphism and HFE mutations may add some valuable information on the interplay linking iron metabolism, inflammation and immunity in autoimmune diseases such as SLE and RA.
format Online
Article
Text
id pubmed-10671518
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106715182023-11-14 Frequency Evaluation of the Interleukin-6 −174G>C Polymorphism and Homeostatic Iron Regulator (HFE) Mutations as Disease Modifiers in Patients Affected by Systemic Lupus Erythematosus and Rheumatoid Arthritis Carini, Mattia Fredi, Micaela Cavazzana, Ilaria Bresciani, Roberto Ferrari, Fabiana Monti, Eugenio Franceschini, Franco Biasiotto, Giorgio Int J Mol Sci Article Autoimmune diseases are generally characterized by a multifactorial etiology and are often associated with a genetic predisposition. Both iron metabolism and the inflammatory cytokine system have been shown to play a pivotal role in the dysregulation of the immune response in many different autoimmune conditions, rheumatologic diseases included. The purpose of this work was to analyze the frequency of mutations altering the expression of IL-6 or influencing iron metabolism in patients affected by autoimmune diseases such as Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE). In this study, 144 patients were enrolled: 77 and 67 patients were affected by RA and SLE, respectively. In these cohorts, the frequency of the IL-6 polymorphism −174G>C located in the IL-6 gene promoter was tested. Moreover, the frequencies of the three HFE gene variations associated with iron overload were analyzed: p.His63Asp, p.Ser65Cys and p.Cys282Tyr. The two mutations p.His63Asp and p.Ser65Cys in the HFE gene did not reach statistical significance in any of the comparisons, regardless of the statistical model, cohorts of patients and control populations analyzed. The frequencies of the p.Cys282Tyr mutation and the IL-6 polymorphism −174G>C were found to be overall significantly decreased in RA and SLE patients when the Dominant model and Allele contrast were adopted with both the Odds Ratio and Chi-square. Although further investigation is needed, the examination of the frequencies of the −174G>C IL-6 promoter polymorphism and HFE mutations may add some valuable information on the interplay linking iron metabolism, inflammation and immunity in autoimmune diseases such as SLE and RA. MDPI 2023-11-14 /pmc/articles/PMC10671518/ /pubmed/38003490 http://dx.doi.org/10.3390/ijms242216300 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Carini, Mattia
Fredi, Micaela
Cavazzana, Ilaria
Bresciani, Roberto
Ferrari, Fabiana
Monti, Eugenio
Franceschini, Franco
Biasiotto, Giorgio
Frequency Evaluation of the Interleukin-6 −174G>C Polymorphism and Homeostatic Iron Regulator (HFE) Mutations as Disease Modifiers in Patients Affected by Systemic Lupus Erythematosus and Rheumatoid Arthritis
title Frequency Evaluation of the Interleukin-6 −174G>C Polymorphism and Homeostatic Iron Regulator (HFE) Mutations as Disease Modifiers in Patients Affected by Systemic Lupus Erythematosus and Rheumatoid Arthritis
title_full Frequency Evaluation of the Interleukin-6 −174G>C Polymorphism and Homeostatic Iron Regulator (HFE) Mutations as Disease Modifiers in Patients Affected by Systemic Lupus Erythematosus and Rheumatoid Arthritis
title_fullStr Frequency Evaluation of the Interleukin-6 −174G>C Polymorphism and Homeostatic Iron Regulator (HFE) Mutations as Disease Modifiers in Patients Affected by Systemic Lupus Erythematosus and Rheumatoid Arthritis
title_full_unstemmed Frequency Evaluation of the Interleukin-6 −174G>C Polymorphism and Homeostatic Iron Regulator (HFE) Mutations as Disease Modifiers in Patients Affected by Systemic Lupus Erythematosus and Rheumatoid Arthritis
title_short Frequency Evaluation of the Interleukin-6 −174G>C Polymorphism and Homeostatic Iron Regulator (HFE) Mutations as Disease Modifiers in Patients Affected by Systemic Lupus Erythematosus and Rheumatoid Arthritis
title_sort frequency evaluation of the interleukin-6 −174g>c polymorphism and homeostatic iron regulator (hfe) mutations as disease modifiers in patients affected by systemic lupus erythematosus and rheumatoid arthritis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671518/
https://www.ncbi.nlm.nih.gov/pubmed/38003490
http://dx.doi.org/10.3390/ijms242216300
work_keys_str_mv AT carinimattia frequencyevaluationoftheinterleukin6174gcpolymorphismandhomeostaticironregulatorhfemutationsasdiseasemodifiersinpatientsaffectedbysystemiclupuserythematosusandrheumatoidarthritis
AT fredimicaela frequencyevaluationoftheinterleukin6174gcpolymorphismandhomeostaticironregulatorhfemutationsasdiseasemodifiersinpatientsaffectedbysystemiclupuserythematosusandrheumatoidarthritis
AT cavazzanailaria frequencyevaluationoftheinterleukin6174gcpolymorphismandhomeostaticironregulatorhfemutationsasdiseasemodifiersinpatientsaffectedbysystemiclupuserythematosusandrheumatoidarthritis
AT brescianiroberto frequencyevaluationoftheinterleukin6174gcpolymorphismandhomeostaticironregulatorhfemutationsasdiseasemodifiersinpatientsaffectedbysystemiclupuserythematosusandrheumatoidarthritis
AT ferrarifabiana frequencyevaluationoftheinterleukin6174gcpolymorphismandhomeostaticironregulatorhfemutationsasdiseasemodifiersinpatientsaffectedbysystemiclupuserythematosusandrheumatoidarthritis
AT montieugenio frequencyevaluationoftheinterleukin6174gcpolymorphismandhomeostaticironregulatorhfemutationsasdiseasemodifiersinpatientsaffectedbysystemiclupuserythematosusandrheumatoidarthritis
AT franceschinifranco frequencyevaluationoftheinterleukin6174gcpolymorphismandhomeostaticironregulatorhfemutationsasdiseasemodifiersinpatientsaffectedbysystemiclupuserythematosusandrheumatoidarthritis
AT biasiottogiorgio frequencyevaluationoftheinterleukin6174gcpolymorphismandhomeostaticironregulatorhfemutationsasdiseasemodifiersinpatientsaffectedbysystemiclupuserythematosusandrheumatoidarthritis